IMTX — Immatics N.V.

—
Nasdaq · Health Care · Biotechnology · CIK 1809196 ·
Last close
$6.29
Market Cap
$957.50M
52W High
$12.41
52W Low
$6.06
ADV30
1,161,640
Next earnings
2026-11-10

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 6,923,000 — -78,542,000 -76,022,000 565,723,000 276,614,000 127,224,000
Jun 2026 9,144,000 — -67,204,000 -62,492,000 485,735,000 232,459,000 86,110,000
Mar 2026 7,612,000 — -66,064,000 -57,814,000 543,264,000 301,332,000 87,463,000
Dec 2025 19,761,000 — -38,881,000 -35,698,000 562,337,000 345,918,000 78,238,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-205,869,000
Investing CF
$57,494,000
Financing CF
$119,122,000
CapEx
$-3,746,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.89
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-906,294,000
Inventory
—
Receivables
$6,664,000
ST Investments
$160,891,000
EBIT TTM
$-205,896,000
Pretax Income TTM
$-206,764,000
Interest Exp TTM
$868,000
Analysts
7

Yahoo Snapshot (yfinance, live)

Total Revenue
$41,704,000
EBITDA
$-218,028,992
Free Cash Flow
$-126,542,624
Enterprise Value
$822,760,896
Total Cash
$393,350,016
Total Debt
$14,606,000
Shares Out
152,225,077
Trailing EPS
$-1.85
Book Value
$3.39
ROE
-47.8%
ROA
-26.9%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 48,266,000 -182,016,000 -196,447,000 562,337,000 78,238,000 484,099,000 -176,626,000
Dec 2024 155,835,000 -38,615,000 15,218,000 696,146,000 121,304,000 574,842,000 -158,030,000
Dec 2023 53,997,000 -101,725,000 -94,649,000 509,965,000 292,347,000 217,618,000 18,228,000
Dec 2022 172,831,000 29,954,000 27,703,000 407,820,000 204,467,000 203,353,000 100,131,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.07

Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)

max pain strike: $7.00 · spot: $6.10 · call volume: 156 · put volume: 9

Peers — same industry

TickerNameMarket CapLastDaily %
ODTX Odyssey Therapeutics, Inc. $931.07M $19.37 —
PRME Prime Medicine, Inc. $854.20M $3.84 —
INBX Inhibrx Biosciences, Inc. $1.09B $74.18 —
BBTX Bambusa Therapeutics, Inc. $832.91M $16.35 —
MGTX MeiraGTx Holdings plc $826.80M $8.46 —

News headlines (Yahoo Finance, 1h cache)

Immatics (IMTX) Reports Q3 Loss, Lags Revenue Estimates
2026-11-10 12:15 · Yahoo
Immatics: Q3 Earnings Snapshot
2026-11-10 12:13 · Yahoo
Immatics Announces Third Quarter 2026 Financial Results and Business Update
2026-11-10 12:00 · Yahoo
Immatics (IMTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
2026-11-09 14:00 · Yahoo
Immatics (IMTX) PRAME Data Puts A Pricey Valuation Back In Focus
2026-11-01 00:21 · Yahoo
Immatics (IMTX) Stock Looks Stretched As PRAME Trial Data Impresses
2026-10-29 01:09 · Yahoo
Should Updated Trial Results Require Action From Immatics (IMTX) Investors?
2026-10-25 03:20 · Yahoo
Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting
2026-10-24 06:30 · Yahoo
Immatics and 4 More Stocks See Action From Activist Investors
2026-09-04 22:59 · Yahoo
Immatics Announces $150 Million Underwritten Offering
2026-08-25 11:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.